| Date | Form | Description | Docs | XBRL | Pages |
| 09/27/17 | 8-K | Current report filing |
|
3 | |
| 09/26/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/26/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/26/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/26/17 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 09/13/17 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
15 | |
| 09/11/17 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/11/17 | 3/A | Initial statement of beneficial ownership of securities |
|
2 | |
| 09/08/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/08/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...